The association between three promoter polymorphisms of IL-10 and inflammatory bowel diseases (IBD): a meta-analysis

Autoimmunity. 2014 Feb;47(1):27-39. doi: 10.3109/08916934.2013.843672. Epub 2013 Oct 16.

Abstract

Aim: To assess the relationship of the Interleukin-10 (IL-10) -1082G/A (rs1800896), -819C/T (rs1800871) and -592C/A (rs1800872) polymorphism with inflammatory bowel disease (IBD) by means of meta-analysis.

Methods: Published data addressing the association between polymorphism of the IL-10 with Crohn's disease (CD) and Ulcerative colitis (UC) were selected from electronic databases. A total of 17 studies including 4132 cases and 5109 controls were included in this meta-analysis which detected whether -1082G/A, -819C/T and -592C/A polymorphism were associated with CD or UC susceptibility.

Result: The IL-10 -819C/T and -519C/A variant allele observed a significant association with UC (OR 1.16, 95%CI 1.03-1.31 and OR 1.19, 95%CI 1.03-1.38) not CD while there is no significant association between -1082G/A and UC or CD.

Conclusion: The IL-10 -819C/T and -592C/A polymorphisms contribute to susceptibility to UC, but IL-10 -1082G/A polymorphism neither associated with CD nor UC.

Publication types

  • Meta-Analysis

MeSH terms

  • Alleles
  • Gene Frequency
  • Genetic Association Studies*
  • Genetic Predisposition to Disease
  • Genotype
  • Humans
  • Inflammatory Bowel Diseases / genetics*
  • Interleukin-10 / genetics*
  • Odds Ratio
  • Polymorphism, Genetic*
  • Polymorphism, Single Nucleotide
  • Population Groups / genetics
  • Promoter Regions, Genetic*
  • Publication Bias

Substances

  • Interleukin-10